RecruitingNot ApplicableNCT07217613

Prospective Evaluation of Silk Fibroin Incision Dressings in ACL Reconstruction

Prospective Evaluation of Silk Fibroin Versus 2-Octyl Cyanoacrylate Incision Dressings Following ACL Reconstruction


Sponsor

NYU Langone Health

Enrollment

100 participants

Start Date

Oct 14, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to compare the incidence of early postoperative skin complications including allergic contact dermatitis, blistering, and erythema between silk fibroin incision dressings and cyanoacrylate closure in patients undergoing anterior cruciate ligament reconstruction.


Eligibility

Min Age: 14 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called cyanoacrylate-based closure system and a medical device called silk fibroin-based incision dressing for people with anterior cruciate ligament reconstruction. The study is currently recruiting participants at 1 location. People eligible for this study include aged 14 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEsilk fibroin-based incision dressing

Applied sterile, hydrophobic, hypoallergenic dressing remains in place for 14-21 days, unless removal is clinically indicated (e.g., saturation, detachment, suspected allergic contact dermatitis, or at provider discretion).

DEVICEcyanoacrylate-based closure system

Applied per standard NYU practice; dressing remains in place per routine protocol.


Locations(1)

NYU Langone Health

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07217613


Related Trials